Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bernstein

Showing results (641-650 of 659) with videos related to

Pageof 66
Sort By:
Communications Biology|October 29, 2025
Exposure of mice to environmentally relevant per- and polyfluoroalkyl substances (PFAS) alters the sperm epigenomeLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Environmental Research|April 22, 2026
Multigenerational exposure to per- and polyfluoroalkyl substances (PFAS) negatively impacts the reproductive health of male miceLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Journal of Medicinal Chemistry|November 5, 1997
Orally active trifluoromethyl ketone inhibitors of human leukocyte elastaseC A Veale, P R Bernstein, C M Bohnert, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activityDean G Brown, Peter R Bernstein, Ye Wu, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
ESMO Open|August 14, 2025
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriersM Perachino, E Blondeaux, V Delucchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2024
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriersL Arecco, M Bruzzone, R Bas, et al.
Journal of Medicinal Chemistry|December 10, 2020
Discovery of a Potent and Selective PI3Kδ Inhibitor (<i>S</i>)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4<i>H</i>-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer ModelsManojkumar R Shukla, Sukanya Patra, Mahip Verma, et al.
Bioorganic & Medicinal Chemistry|October 29, 2020
Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterizationNavnath P Karche, Mandar Bhonde, Neelima Sinha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort studyA Toss, E Blondeaux, E Tenedini, et al.
Pageof 66

Showing results (641-650 of 659) with videos related to

Sort By:
Pageof 66
Communications Biology|October 29, 2025
Exposure of mice to environmentally relevant per- and polyfluoroalkyl substances (PFAS) alters the sperm epigenomeLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Environmental Research|April 22, 2026
Multigenerational exposure to per- and polyfluoroalkyl substances (PFAS) negatively impacts the reproductive health of male miceLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Journal of Medicinal Chemistry|November 5, 1997
Orally active trifluoromethyl ketone inhibitors of human leukocyte elastaseC A Veale, P R Bernstein, C M Bohnert, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activityDean G Brown, Peter R Bernstein, Ye Wu, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
ESMO Open|August 14, 2025
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriersM Perachino, E Blondeaux, V Delucchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2024
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriersL Arecco, M Bruzzone, R Bas, et al.
Journal of Medicinal Chemistry|December 10, 2020
Discovery of a Potent and Selective PI3Kδ Inhibitor (<i>S</i>)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4<i>H</i>-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer ModelsManojkumar R Shukla, Sukanya Patra, Mahip Verma, et al.
Bioorganic & Medicinal Chemistry|October 29, 2020
Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterizationNavnath P Karche, Mandar Bhonde, Neelima Sinha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort studyA Toss, E Blondeaux, E Tenedini, et al.
Pageof 66